{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T18:45:27Z","timestamp":1760985927903},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T00:00:00Z","timestamp":1587513600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,5,19]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Purpose<\/jats:title>\n                  <jats:p>Highly publicized safety issues arising from poor sterile compounding practices in facilities around the United States have garnered substantial attention in recent years. This attention has led to increased scrutiny of health systems by regulatory bodies, new regulatory requirements, and changes to existing regulations or their interpretation. Health systems are often resource constrained, and the added work resulting from this scrutiny challenges pharmacy departments in meeting regulatory requirements and United States Pharmacopeia chapter 797 standards for sterile compounding. This article describes the creation of a dedicated compounding compliance team (CCT) and the team\u2019s responsibilities in support of pharmacy operations in achieving compliance with those standards.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Summary<\/jats:title>\n                  <jats:p>Visits to our organization by several regulatory bodies resulted in findings that required substantial work in order to achieve compliance with sterile compounding standards. Given the number and complexity of findings and the need for timely resolution, it was felt that specialized staff were needed to understand, evaluate, and correct identified deficiencies and help the already overburdened staff and leadership comply with existing standards. A CCT was formed, and work was simultaneously initiated on ensuring proper credentialing and training of all compounding staff, development of standard operating procedures, improvements in facilities, environmental monitoring, equipment certifications, practice auditing, and documentation. Key activities of the team included strategic planning, building relationships, communicating with stakeholders, self-education, and record keeping. Key partners included environmental services, facilities, and infection prevention and control personnel and departmental staff and leaders.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>The formation and collaborative work of a CCT at an academic medical center was successful in changing the culture of the organization and achieving compliance during visits from several regulatory agencies.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ajhp\/zxaa063","type":"journal-article","created":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T05:58:33Z","timestamp":1587535113000},"page":"882-891","source":"Crossref","is-referenced-by-count":7,"title":["A compounding compliance team at an academic medical center"],"prefix":"10.1093","volume":"77","author":[{"given":"Bruce W","family":"Chaffee","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Michigan Medicine, Ann Arbor, MI, and College of Pharmacy, University of Michigan, Ann Arbor, MI"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamie C","family":"Tharp","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Michigan Medicine, Ann Arbor, MI, and College of Pharmacy, University of Michigan, Ann Arbor, MI"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John S","family":"Clark","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Michigan Medicine, Ann Arbor, MI, and College of Pharmacy, University of Michigan, Ann Arbor, MI"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stanley","family":"Kent","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Michigan Medicine, Ann Arbor, MI, and College of Pharmacy, University of Michigan, Ann Arbor, MI"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2020,4,22]]},"reference":[{"key":"2020051904580566000_CIT0001","author":"The Pew Charitable Trusts"},{"key":"2020051904580566000_CIT0002","first-page":"289","article-title":"Federal regulation of parenterals","volume-title":"Pharmaceutical Dosage Forms: Parenteral Medications.","author":"Munson","year":"1993"},{"key":"2020051904580566000_CIT0003","first-page":"1","article-title":"Perspective on the use of parenteral solutions","volume-title":"Parenteral Products","author":"Groves","year":"1973"},{"key":"2020051904580566000_CIT0004","first-page":"927","article-title":"Abstract of proposed changes with the new standards and descriptions. Eleventh revision","volume":"23","author":"United States Pharmacopaea","year":"1934","journal-title":"J Am Pharm Assoc."},{"key":"2020051904580566000_CIT0005","author":"Baxter"},{"key":"2020051904580566000_CIT0006","first-page":"5","article-title":"The history of intravenous therapy","volume":"19","author":"Millam","year":"1996","journal-title":"J Intraven Nurs."},{"key":"2020051904580566000_CIT0007","first-page":"111","article-title":"Plastic containers for parenterals","volume-title":"Pharmaceutical Dosage Forms: Parenteral Medications Volume 2","author":"Solomon","year":"1984"},{"key":"2020051904580566000_CIT0008","author":"Sandia National Laboratories"},{"key":"2020051904580566000_CIT0009","first-page":"1","article-title":"Willis Whitfield, inventor of modern-day laminar-flow clean room, passes away","volume":"64","author":"Clark","year":"2012","journal-title":"Sandia LabNews"},{"key":"2020051904580566000_CIT0010","first-page":"37","article-title":"Microbiological studies of laminar flow rooms","volume":"21","author":"Whitfield","year":"1967","journal-title":"Bull Parenter Drug Assoc."},{"key":"2020051904580566000_CIT0011","first-page":"10","article-title":"Designing for the laminar flow environment","volume":"8","author":"Whitfield","year":"1969","journal-title":"Contam Control."},{"key":"2020051904580566000_CIT0012","first-page":"266","article-title":"A pharmacy centralized intravenous additive service","volume":"22","author":"Holysko Sister","year":"1965","journal-title":"Am J Hosp Pharm."},{"key":"2020051904580566000_CIT0013","first-page":"136","article-title":"Pharmacists and nurses benefit from an I.V. additive program","volume":"42","author":"Ragland","year":"1968","journal-title":"Hospitals."},{"key":"2020051904580566000_CIT0014","first-page":"92","article-title":"I.V. additive program belongs in the pharmacy","volume":"43","author":"Brown","year":"1969","journal-title":"Hospitals."},{"key":"2020051904580566000_CIT0015","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1177\/106002806700100804","article-title":"A feasibility study of a centralized intravenous admixture service","volume":"1","author":"Wenger","year":"1967","journal-title":"Drug Intelligence."},{"key":"2020051904580566000_CIT0016","first-page":"111","article-title":"Parenteral products in hospital practice","volume-title":"Pharmaceutical Dosage Forms: Parenteral Medications Volume 2","author":"Levchuk","year":"1984"},{"key":"2020051904580566000_CIT0017","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1177\/2168479015620833","article-title":"Improving the quality of compounded sterile drug products: a historical perspective","volume":"50","author":"Cantrell","year":"2016","journal-title":"Ther Innov Reg Sci."},{"key":"2020051904580566000_CIT0018","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jhin.2015.04.007","article-title":"Systematic review and meta-analysis of the risk of microbial contamination of parenteral doses prepared under accepting techniques in clinical and pharmaceutical environments","volume":"91","author":"Austin","year":"2015","journal-title":"J Hosp Infect."},{"key":"2020051904580566000_CIT0019","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.2146\/ajhp130112","article-title":"History of sterile compounding in U.S. hospitals: learning from the tragic lessons of the past","volume":"70","author":"Myers","year":"2013","journal-title":"Am J Health-Syst Pharm."},{"key":"2020051904580566000_CIT0020","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1056\/NEJMoa1213978","article-title":"Fungal infections associated with contaminated methylprednisolone injections","volume":"369","author":"Smith","year":"2013","journal-title":"N Engl J Med."},{"key":"2020051904580566000_CIT0021","first-page":"839","article-title":"Multistate outbreak of fungal infection associated with injection of methylprednisolone acetate solution from a single compounding pharmacy\u2014United States, 2012","volume":"61","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"2020051904580566000_CIT0022","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1056\/NEJMp1712905","article-title":"Toward better-quality compounded drugs \u2014an update from the FDA","volume":"377","author":"Woodcock","year":"2017","journal-title":"N Engl J Med."},{"key":"2020051904580566000_CIT0023","first-page":"8","article-title":"Regulators faulted for inadequate compounding pharmacy oversight","volume":"70","author":"Traynor","year":"2013","journal-title":"Am J Health-Syst Pharm."},{"key":"2020051904580566000_CIT0024","doi-asserted-by":"crossref","first-page":"424","DOI":"10.2146\/news160020","article-title":"Compounding oversight a work in progress for states, FDA","volume":"73","author":"Traynor","year":"2016","journal-title":"Am J Health-Syst Pharm."},{"key":"2020051904580566000_CIT0025","first-page":"88","article-title":"NABP to inspect compounding pharmacies","volume":"70","author":"Traynor","year":"2013","journal-title":"Am J Health-Syst Pharm."},{"key":"2020051904580566000_CIT0026","first-page":"480","article-title":"HR3204\u2013the Drug Quality and Security Act: what does it say? What does it mean? What happens now?","volume":"17","year":"2013","journal-title":"Int J Pharm Compd."},{"key":"2020051904580566000_CIT0027","author":"Food and Drug Administration"},{"key":"2020051904580566000_CIT0028","author":"Palmer"},{"key":"2020051904580566000_CIT0029","article-title":"Compounding facilities assessment and planning: a focus on USP &lt;797&gt; and USP &lt;800&gt;","author":"Clark","year":"","journal-title":"Am J Health-System Pharm"},{"key":"2020051904580566000_CIT0030","article-title":"a microbiological monitoring program and control of compounding facilities","author":"Tharp","year":"","journal-title":"Am J Health-System Pharm"},{"key":"2020051904580566000_CIT0031","article-title":"Development of a sterile compounding training and competency program at a large academic medical center","author":"Penzien","year":"","journal-title":"Am J Health-System Pharm"},{"key":"2020051904580566000_CIT0032","article-title":"Impact of enhanced compounding vigilance: three perspectives","author":"Lucarotti","year":"","journal-title":"Am J Health-System Pharm"}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/77\/11\/882\/33235964\/zxaa063.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/77\/11\/882\/33235964\/zxaa063.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T08:58:23Z","timestamp":1589878703000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/77\/11\/882\/5823589"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,22]]},"references-count":32,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2020,4,22]]},"published-print":{"date-parts":[[2020,5,19]]}},"URL":"https:\/\/doi.org\/10.1093\/ajhp\/zxaa063","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,6,1]]},"published":{"date-parts":[[2020,4,22]]}}}